1.Laboratory evaluation of blood coagulation system in FFP.
Sang Won CHO ; Gyeong Ran CHOI ; Tai Ju HWANG ; Dong Wook YANG
Korean Journal of Blood Transfusion 1992;3(1):35-40
No abstract available.
Blood Coagulation*
2.Genetic variation of the Apo Al-CIII-AIV gene cluster in hypertriglyceridemic patients with chronic renal failure undergoing hemodialysis.
Gyeong Ran CHOI ; Soon Pal SUH ; Jeong Wwon SONG ; Seung Jung KEE ; Jong Hee SHIN ; Dong Wook RYANG
Journal of Korean Medical Science 2000;15(3):289-294
Many patients with chronic renal failure (CRF) requiring hemodialysis present with hypertriglyceridemia (HTG). But the exact cause of HTG in CRF is still unknown. Genetic variation of the apo AI-CIII-AIV gene cluster was reported to be associated with primary HTG, atherosclerosis and coronary artery disease. This study was designed to evaluate the association between the restriction fragment length polymorphism (RFLP) of the apo AI-CIII-AIV gene cluster and HTG in patients with CRF undergoing hemodialysis. Genetic variations of the apo AI-CIII-AIV gene cluster were analysed in peripheral leukocyte samples from 59 patients with CRF undergoing hemodialysis: 17 patients with HTG (CRF-HTG) and 42 patients without HTG (CRF-NTG). The RFLP was achieved through the digestion of PCR products by two restriction enzymes, SstI and MspI. The frequency of SstI minor allele (S2) in CRF-HTG was 0.44, which was significantly higher than that in CRF-NTG (0.17). Frequencies of MspI minor allele (M2) in CRF-HTG and CRF-NTG were not significantly different (0.5 vs 0.32) (p=0.07). Frequencies of S2-M2 genotype were 0.65 in CRF-HTG, and 0.27 in CRF-NTG (p>0.005). These data indicate that genetic variation of the apo AI-CIII-AIV gene cluster may serve as one of the causes of HTG in CRF.
Apolipoprotein A-I/genetics*
;
Apolipoproteins A/genetics*
;
Apolipoproteins C/genetics*
;
Apolipoproteins C/blood
;
Cholesterol/blood
;
Female
;
Human
;
Hypertriglyceridemia/genetics*
;
Hypertriglyceridemia/complications
;
Kidney Failure, Chronic/genetics*
;
Kidney Failure, Chronic/complications
;
Lipoproteins, HDL Cholesterol/blood
;
Male
;
Middle Age
;
Multigene Family*
;
Renal Dialysis
;
Triglycerides/blood
;
Variation (Genetics)*
3.Genetic variation of the Apo Al-CIII-AIV gene cluster in hypertriglyceridemic patients with chronic renal failure undergoing hemodialysis.
Gyeong Ran CHOI ; Soon Pal SUH ; Jeong Wwon SONG ; Seung Jung KEE ; Jong Hee SHIN ; Dong Wook RYANG
Journal of Korean Medical Science 2000;15(3):289-294
Many patients with chronic renal failure (CRF) requiring hemodialysis present with hypertriglyceridemia (HTG). But the exact cause of HTG in CRF is still unknown. Genetic variation of the apo AI-CIII-AIV gene cluster was reported to be associated with primary HTG, atherosclerosis and coronary artery disease. This study was designed to evaluate the association between the restriction fragment length polymorphism (RFLP) of the apo AI-CIII-AIV gene cluster and HTG in patients with CRF undergoing hemodialysis. Genetic variations of the apo AI-CIII-AIV gene cluster were analysed in peripheral leukocyte samples from 59 patients with CRF undergoing hemodialysis: 17 patients with HTG (CRF-HTG) and 42 patients without HTG (CRF-NTG). The RFLP was achieved through the digestion of PCR products by two restriction enzymes, SstI and MspI. The frequency of SstI minor allele (S2) in CRF-HTG was 0.44, which was significantly higher than that in CRF-NTG (0.17). Frequencies of MspI minor allele (M2) in CRF-HTG and CRF-NTG were not significantly different (0.5 vs 0.32) (p=0.07). Frequencies of S2-M2 genotype were 0.65 in CRF-HTG, and 0.27 in CRF-NTG (p>0.005). These data indicate that genetic variation of the apo AI-CIII-AIV gene cluster may serve as one of the causes of HTG in CRF.
Apolipoprotein A-I/genetics*
;
Apolipoproteins A/genetics*
;
Apolipoproteins C/genetics*
;
Apolipoproteins C/blood
;
Cholesterol/blood
;
Female
;
Human
;
Hypertriglyceridemia/genetics*
;
Hypertriglyceridemia/complications
;
Kidney Failure, Chronic/genetics*
;
Kidney Failure, Chronic/complications
;
Lipoproteins, HDL Cholesterol/blood
;
Male
;
Middle Age
;
Multigene Family*
;
Renal Dialysis
;
Triglycerides/blood
;
Variation (Genetics)*
4.Clinical Manifestations and Treatment Outcomes of Eosinophilic Gastroenteritis in Children.
Jong Sub CHOI ; Shin Jie CHOI ; Kyung Jae LEE ; Ahlee KIM ; Jung Kyung YOO ; Hye Ran YANG ; Jin Soo MOON ; Ju Young CHANG ; Jae Sung KO ; Gyeong Hoon KANG
Pediatric Gastroenterology, Hepatology & Nutrition 2015;18(4):253-260
PURPOSE: The aim of the present study was to investigate the clinical features and outcome of eosinophilic gastroenteritis (EGE) in children. METHODS: Our study enrolled 24 children who were diagnosed with EGE from 1993 to 2014 at the Department of Pediatrics, Seoul National University Children's Hospital. The patients' clinical manifestations, treatments, and outcomes were reviewed from the medical records. RESULTS: The mean age at diagnosis was 5.3 years. Most patients had gastrointestinal symptoms including diarrhea (54.2%) and abdominal pain (45.8%). Peripheral eosinophilia was present in 91.7% of the patients. Thirteen patients (54.2%) showed anemia, and 15 patients (62.5%) had hypoalbuminemia. EGE was classified as mucosal, subserosal, or muscular in 75.0%, 20.8%, and 4.2% of cases, respectively. Three patients showed gastroduodenal ulcers upon endoscopic analysis. A history of allergy was reported in 13 patients, including atopic dermatitis, allergic rhinitis, and asthma. Five patients (20.8%) improved with food restrictions. Among the 19 patients treated with steroids, 11 (57.9%) discontinued steroid treatment without subsequent relapse, 4 (21.1%) relapsed after ceasing steroid treatment, and 4 (21.1%) showed no response to steroids. Two patients who were resistant to steroids underwent therapeutic surgery. The presence of gastroduodenal ulcers was significantly associated with relapse and steroid resistance. CONCLUSION: A high suspicion of EGE is warranted when children have nonspecific gastrointestinal symptoms and peripheral eosinophilia. Most patients improved with food restrictions or steroid treatment, although one-third of patients showed a relapse or steroid resistance.
Abdominal Pain
;
Anemia
;
Asthma
;
Child*
;
Dermatitis, Atopic
;
Diagnosis
;
Diarrhea
;
Eosinophilia
;
Eosinophils*
;
Gastroenteritis*
;
Humans
;
Hypersensitivity
;
Hypoalbuminemia
;
Medical Records
;
Pediatrics
;
Peptic Ulcer
;
Recurrence
;
Rhinitis
;
Seoul
;
Steroids
;
Ulcer
5.A Novel DHCR7 Mutation in a Smith-Lemli-Opitz Syndrome Infant Presenting with Neonatal Cholestasis.
Jae Sung KO ; Byung Sam CHOI ; Jeong Kee SEO ; Jee Yeon SHIN ; Jong Hee CHAE ; Gyeong Hoon KANG ; Ran LEE ; Chang Seok KI ; Jong Won KIM
Journal of Korean Medical Science 2010;25(1):159-162
Smith-Lemli-Opitz syndrome (SLOS) is an autosomal recessive malformation syndrome caused by a defect in cholesterol biosynthesis. The incidence is very low in Asians and only one case has been reported in Korea thus far. Recently, we found an infant with neonatal cholestasis. He had microcephaly, ambiguous genitalia, cleft palate, syndactyly of toes, patent ductus arteriosus and hypertrophic pyloric stenosis. The serum cholesterol was decreased and serum 7-dehydrocholesterol was markedly elevated. Genetic analysis of the DHCR7 gene identified a novel missense mutation (Pro227Ser) as well as a known mutation (Gly303Arg) previously identified in a Japanese patient with SLOS. Although rare in Korea, SLOS should be considered in the differential diagnosis of neonatal cholestasis, especially in patients with multiple congenital anomalies and low serum cholesterol levels.
Amino Acid Substitution
;
Base Sequence
;
Cholestasis/*diagnosis
;
Ductus Arteriosus, Patent/diagnosis
;
Electroencephalography
;
Humans
;
Infant, Newborn
;
Liver/pathology/ultrasonography
;
Male
;
*Mutation, Missense
;
Oxidoreductases Acting on CH-CH Group Donors/*genetics
;
Phenotype
;
Smith-Lemli-Opitz Syndrome/diagnosis/*genetics
6.Stepwise Endoscopy Based on Sigmoidoscopy in Evaluating Pediatric Graft-versus-Host Disease.
Kyung Jae LEE ; Shin Jie CHOI ; Hye Ran YANG ; Ju Yuong CHANG ; Hyoung Jin KANG ; Hee Young SHIN ; Gyeong Hoon KANG ; Jae Sung KO ; Jin Soo MOON
Pediatric Gastroenterology, Hepatology & Nutrition 2016;19(1):29-37
PURPOSE: The aim of our study was to establish a safe and convenient diagnostic method for acute gastrointestinal (GI) graft-versus-host disease (GVHD) in children by determining the sensitivity and negative predictive values of upper and lower endoscopic biopsies for children suspected of GI GVHD. METHODS: Patients suspected of GI GVHD who received endoscopic evaluation within 100 days after stem cell transplantation and endoscopies between January 2012 and March 2014 in Seoul National University Children's Hospital were included in our study. RESULTS: Fifteen patients with a total of 20 endoscopic procedures were included in our study. Sensitivity at the esophagus, stomach, and duodenum were 22.2%, 30.0%, and 80.0%, respectively. Negative predictive values at the esophagus, stomach, and duodenum were 22.2%, 30.0%, and 60.0%, respectively. Overall sensitivity and negative predictive values of upper endoscopic biopsy for GVHD were 77.8% and 50.0%, respectively. Overall sensitivity and negative predictive values of lower endoscopic biopsy for GVHD were 88.9% and 66.7%, respectively. CONCLUSION: We recommend flexible sigmoidoscopy as a safe and accurate diagnostic tool for GVHD, similar to other studies reported previously. However, if there is no evidence of GVHD on sigmoidoscopy with high index of suspicion of GI bleeding, full colonoscopy and upper endoscopy should be considered.
Biopsy
;
Child
;
Colonoscopy
;
Duodenum
;
Endoscopy*
;
Esophagus
;
Graft vs Host Disease*
;
Hemorrhage
;
Humans
;
Seoul
;
Sigmoidoscopy*
;
Stem Cell Transplantation
;
Stomach
7.Unruptured Aneurysm of the Left Sinus of Valsalva Presenting as Acute Coronary Syndrome: A Case Report.
So Ra PARK ; Jin Yong HWANG ; Yong Ran KANG ; Min Gyeong KANG ; Mung Gi SEO ; Sung Ji PARK ; Bong Ryong CHOI ; Choong Hwan KWAK
Korean Circulation Journal 2006;36(7):549-552
We report here on a case of a 34-year-old man with unruptured aneurysm of the left sinus of Valsalva, and he presented with acute coronary syndrome due to the putative dynamic compression of both the left main coronary artery and the left circumflex coronary artery. The cardiac multislice computed tomography scanning and coronary angiogram revealed the compression of the two coronary arteries by the aneurysm of the left sinus of Valsalva. Aneurysmectomy was performed for surgical repair. After the surgery, the patient stayed asymptomatic during the 6-months of follow-up.
Acute Coronary Syndrome*
;
Adult
;
Aneurysm*
;
Coronary Vessels
;
Follow-Up Studies
;
Humans
;
Multidetector Computed Tomography
;
Sinus of Valsalva*
8.Abnormalities of Serum Lipid, Lipoprotein and Apolipoprotein in Both Normotriglyceridemic and Hypertriglyceridemic Patients with Chronic Renal Failure on Chronic Hemodialysis.
Kyu Sung CHO ; Gyeong Ran CHOI ; Seung Jung KEE ; Soo Hyun KIM ; Myung Geun SHIN ; Jong Hee SHIN ; Soon Pal SUH ; Dong Wook RYANG
Korean Journal of Clinical Pathology 1999;19(4):414-419
BACKGROUND: Hypertriglyceridemia (HTG) has been considered a characteristic plasma lipid abnormality in hemodialysis patients with chronic renal failure, but is actually shown in only some of them (30-50%). Also renal dyslipidemia may contribute to atherosclerosis in hemodialysis patients. METHODS: Study population consisted of 34 patients with normotriglyceridemia (NTG), 11 patients with HTG and 47 controls. We measured total cholesterol (TC), triglyceride (TG), high density lipoprotein-cholesterol (HDL-C), apolipoprotein (apo) A-I, apoB, apoC-III and apoE. RESULTS: Compared with controls, the NTG patients had significantly decreased levels of TC, HDL-C, and low density lipoprotein-cholesterol (LDL-C). But HTG patients had significantly increased TG, and TC/HDL-C ratio which were considered to represent the atherogenic indicator and had decreased HDL-C and LDL-C (P <0.001), with significant increase of TG and TC/HDL-C ratio compared with those of NTG patients. In the apolipoprotein profiles, all patients showed decreased levels of apoA-I, apoB, and apoA-I/apoC-III ratio and increased levels of apoC-III and apoC-III/apoE ratio compared with those of controls (P <0.001). Especially, HTG patients had significantly increased levels of apoC-III compared with NTG patients. CONCLUSIONS: So these results indicated that abnormalities of those potentially atherogenic lipid and lipoproteins may contribute to the high incidence of cardiovascular diseases and progression of renal disease in the HTG patients than NTG patients on maintenance hemodialysis.
Apolipoprotein A-I
;
Apolipoprotein C-III
;
Apolipoproteins B
;
Apolipoproteins E
;
Apolipoproteins*
;
Atherosclerosis
;
Cardiovascular Diseases
;
Cholesterol
;
Dyslipidemias
;
Humans
;
Hypertriglyceridemia
;
Incidence
;
Kidney Failure, Chronic*
;
Lipoproteins*
;
Plasma
;
Renal Dialysis*
;
Triglycerides
9.The Review on Characteristics, Pathophysiology and Risk Factors of Irritable Bowel Syndrome.
Mi Jung PARK ; Myung Ae CHOE ; Keum Soon KIM ; Hae Sook HONG ; Kyung Sook LEE ; Jae Sim JEONG ; Young Ran CHAE ; Gyeong Ju AN ; Ki Soo SHIN ; Jung An CHOI
Korean Journal of Rehabilitation Nursing 2005;8(2):129-138
PURPOSE: Irritable bowel syndrome (IBS) is frequently yet little understood disease. Review was performed to promote understanding on the characteristics, pathophysiology, and risk factors of IBS. CONTENT: IBS is characterized by abdom in women and people with higher educational and social background, but there are some controversies. IBS is diagnosed by the Rome II or Manning criteria after excluding organic gastrointestinal diseases. The pathophysioloy is explained by abnormal control mechanism of central and enteric nervous system. Mucosal immunity, secretions, and neurotransmitter are also associated with the hypersensitivity and motility change of bowel function. Stress is known as a major triggering factor and contributed to symptoms. Other risk factors are genetic elements, childhood experiences, inflammation, anxiety, depression, diet, and sleep disorders.
Anxiety
;
Depression
;
Diet
;
Enteric Nervous System
;
Female
;
Gastrointestinal Diseases
;
Humans
;
Hypersensitivity
;
Immunity, Mucosal
;
Inflammation
;
Irritable Bowel Syndrome*
;
Neurotransmitter Agents
;
Risk Factors*
;
Sleep Wake Disorders
10.Clinical Features of Li-Fraumeni Syndrome in Korea
Ran SONG ; Sun-Young KONG ; Wonyoung CHOI ; Eun-Gyeong LEE ; Jaeyeon WOO ; Jai Hong HAN ; Seeyoun LEE ; Han-Sung KANG ; So-Youn JUNG
Cancer Research and Treatment 2024;56(1):334-341
Purpose:
Li-Fraumeni syndrome (LFS) is a hereditary disorder caused by germline mutation in TP53. Owing to the rarity of LFS, data on its clinical features are limited. This study aimed to evaluate the clinical characteristics and prognosis of Korean patients with LFS.
Materials and Methods:
Patients who underwent genetic counseling and confirmed with germline TP53 mutation in the National Cancer Center in Korea between 2011 and 2022 were retrospectively reviewed. Data on family history with pedigree, types of mutation, clinical features, and prognosis were collected.
Results:
Fourteen patients with LFS were included in this study. The median age at diagnosis of the first tumor was 32 years. Missense and nonsense mutations were observed in 13 and one patients, respectively. The repeated mutations were p.Arg273His, p.Ala138Val, and pPro190Leu. The sister with breast cancer harbored the same mutation of p.Ala138Val. Seven patients had multiple primary cancers. Breast cancer was most frequently observed, and other types of tumor included sarcoma, thyroid cancer, pancreatic cancer, brain tumor, adrenocortical carcinoma, ovarian cancer, endometrial cancer, colon cancer, vaginal cancer, skin cancer, and leukemia. The median follow-up period was 51.5 months. Two and four patients showed local recurrence and distant metastasis, respectively. Two patients died of leukemia and pancreatic cancer 3 and 23 months after diagnosis, respectively.
Conclusion
This study provides information on different characteristics of patients with LFS, including types of mutation, types of cancer, and prognostic outcomes. For more appropriate management of these patients, proper genetic screening and multidisciplinary discussion are required.